Chief Financial Officer (CFO)

Accountabilities:

• • Lead all financial, accounting, treasury, and investor-relations activities, maintaining strong financial discipline, transparency, and operational rigor.
  • Develop and execute financing and capitalization strategies aligned with clinical development, growth, and commercialization objectives, partnering closely with the CEO on fundraising and capital formation.
  • Oversee financial planning, reporting, tax compliance, internal controls, audit preparation, and other regulatory requirements.
  • Build scalable financial operations, systems, processes, and teams capable of supporting pharmaceutical R&D, clinical programs, and future commercial activities.
  • Manage cash forecasting, working capital, cost optimization, annual corporate and departmental budgeting, and long-range financial planning.
  • Oversee equity administration, including stock-option accounting and reporting, and coordinate insurance coverage to support effective risk management.
  • Establish and manage a consistent cadence of investor and Board communications while identifying and engaging prospective investors.
  • Lead and support strategic transactions, including mergers and acquisitions, licensing arrangements, strategic partnerships, and other corporate development opportunities.
  • Partner with business development to assess the financial and strategic potential of revenue-generating opportunities and support transaction execution.
  • Provide financial leadership across cross-functional growth initiatives and collaborate with senior leadership and the Board on corporate strategy.
  • Partner with Legal, Compliance, People, and other functions on financial, regulatory, governance, and organizational matters.
  • Strengthen financial processes and organizational readiness as the business progresses toward commercialization and increasingly sophisticated stakeholder requirements.

  Requirements:

  • 10+ years of progressive financial leadership experience within life sciences, biotechnology, pharmaceutical, or related organizations, including experience in clinical-stage companies.
  • Deep expertise in life sciences corporate finance, financial strategy, planning, capital management, and investor relations.
  • Demonstrated success raising capital across private and public markets and developing financing strategies for high-growth organizations.
  • Proven experience leading or supporting complex transactions, including M&A, licensing, IPOs, strategic partnerships, and exits.
  • Advanced knowledge of US GAAP, financial reporting, internal controls, compliance, audit processes, and corporate governance.
  • Experience building scalable finance organizations, systems, processes, and controls in lean or rapidly growing environments.
  • Experience supporting organizations through late-stage clinical development and, ideally, the transition toward early commercialization.
  • Familiarity with venture-backed biotech financing structures, including non-dilutive funding mechanisms and grants.
  • Experience working with investment banks, financial analysts, strategic partners, and other external stakeholders across the biopharma or MedTech ecosystem.
  • Demonstrated ability to prepare organizations for public-company-level financial, reporting, governance, and control requirements.
  • Strong strategic thinking, analytical, problem-solving, and decision-making capabilities, with the ability to translate complex financial information into actionable business insights.
  • Exceptional communication and relationship-building skills, with the credibility to engage effectively with executives, Board members, investors, employees, and external partners.
  • High ethical standards, sound judgment, professionalism, discretion, and the ability to manage sensitive financial and corporate information.
  • Bachelor's degree in finance, accounting, economics, or a related discipline required; an MBA, CPA, or equivalent advanced credential is preferred.
  • Existing relationships within the orthopedic, biopharma, MedTech, investment, or strategic-partner ecosystem are advantageous.

  Benefits:

  • Executive-level opportunity with significant influence over financial strategy, capitalization, and corporate growth.
  • Opportunity to work closely with the CEO, executive leadership team, Board, investors, and strategic partners.
  • High-impact environment supporting the advancement of late-stage clinical development toward commercialization.
  • Broad ownership across finance, accounting, treasury, investor relations, corporate development, and strategic planning.
  • Opportunity to shape scalable financial infrastructure, processes, and teams as the organization grows.
  • Collaborative, lean environment with meaningful visibility and decision-making responsibility.
  • Equal opportunity workplace committed to evaluating candidates based on qualifications, experience, and potential.